CATEGORY: GUT & DIGESTIVE HEALTH
Routine checkup scopes don’t retire on their own. The American Gastroenterological Association’s newest advice argues that, at some point, they should: after about age 75, follow-up colonoscopy for colon polyps and surveillance of Barrett’s esophagus—a change in the lining of the lower food pipe that can precede cancer—become case-by-case decisions rather than standing appointments.1 The arithmetic behind that advice is blunt. In older adults, the update estimates, colonoscopy causes about 26 complications per 1,000 procedures, while screening finds cancer in roughly 2 to 3 people per 1,000.1
The Colonoscopy Math in the Years Past 75
The update, published August 3 in Clinical Gastroenterology and Hepatology, lays out nine advice statements for doctors.1 The colon numbers explain why it was written. Among screened adults aged 76 to 85, colorectal cancer turned up in 0.2% to 0.5%, and advanced polyps in 6% to 8%.1 For people over 75 with a history of low-risk polyps, the five-year chance of developing colorectal cancer was about 0.5%, and about 0.8% after an advanced polyp. Over those same five years, the chance of dying of something else entirely was about 22%. At ten years it was 48%.1 So the update asks doctors to stop booking the next colonoscopy automatically once a patient is past 75. It calls instead for a real conversation weighing benefits, polyp history, overall health and risks, with the decision written into the medical record.1
One Trial Followed Barrett’s Patients for More Than a Decade
The esophagus side rests on quieter numbers. Nine in ten people with Barrett’s esophagus have no precancerous cell changes, and their odds of developing esophageal cancer run around 0.1% to 0.3% per year.1 In one study the update cites, people successfully treated for early Barrett’s-related growths were 40 times more likely to die of another cause than of esophageal cancer.1 The strongest evidence comes from the British BOSS trial, which enrolled 3,453 Barrett’s patients at 109 hospitals. Each person’s schedule was set at random when they joined: an endoscopy every two years, or one only if symptoms appeared. After a median of 12.8 years, survival was essentially identical, with 333 deaths in the surveillance group and 356 in the other.2 A cost-effectiveness analysis cited in the update suggests the age where routine Barrett’s checks stop paying off ranges from 69, for women with serious health problems, to 81, for healthy men.1 And whatever the age, the update says surveillance has no purpose for someone who couldn’t undergo treatment if cancer were found.1 Lead author Audrey Calderwood put it simply: “It may very well be reasonable to stop Barrett’s surveillance or at least give patients the option to stop.”
Guidance Distilled From Evidence, Not a New Experiment
This document is an expert review, not a fresh trial. A panel drew on published studies and added clinical judgment where the data run out, and its statements carry no formal grades of evidence strength.1 It also isn’t a blanket cutoff. Cancer tests usually require around ten extra years of life to be worthwhile, and the latest update keeps monitoring as an option for older people who may need it. What changes is the standard choice. The question matters to a lot of people: the update notes that Americans aged 65 and older are projected to reach 82 million by 2050, nearly a quarter of the population.1 For them, a scope that once got scheduled by habit now comes with a deliberate yes or no.
Key Takeaways
- This guidance focuses on the importance of stopping well rather than abolishing surveillance: for healthy individuals with many years ahead, checkup scopes retain their value.
- Past 75, colonoscopy’s estimated complication rate (about 26 per 1,000 procedures) runs well above its cancer yield (2 to 3 per 1,000 screened).
- The only randomized trial of routine Barrett’s surveillance found it didn’t lengthen life compared with scoping when symptoms appear.
- The advice comes from an expert review of published studies, without formal evidence grading, so it informs a judgment call rather than settling one.
References
- Calderwood AH, et al. AGA Clinical Practice Update on Surveillance of Metaplastic and Premalignant Conditions of the Esophagus and Colorectum in Older Adults: Expert Review. Clinical Gastroenterology and Hepatology. 2026;S1542-3565(26)00441-6. link
- Old O, Jankowski J, Attwood S, et al. Barrett’s Oesophagus Surveillance Versus Endoscopy at Need Study (BOSS): A Randomized Controlled Trial. Gastroenterology. 2025;S0016-5085(25)00587-6. link